Pang Yichuan, Su Li, Fu Yao, Jia Fan, Zhang Chenxi, Cao Xiankun, He Wenxin, Kong Xueqian, Xu Jiake, Zhao Jie, Qin An
Shanghai Key Laboratory of Orthopedic Implants, Department of Orthopaedics, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, China.
Department of Nuclear Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
Bioact Mater. 2020 Sep 23;6(3):712-720. doi: 10.1016/j.bioactmat.2020.09.006. eCollection 2021 Mar.
Breast cancer bone metastasis poses significant challenge for therapeutic strategies. Inside the metastatic environment, osteoclasts and tumor cells interact synergistically to promote cancer progression. In this study, the proprotein convertase furin is targeted due to its critical roles in both tumor cell invasion and osteoclast function. Importantly, the furin inhibitor is specifically delivered by bone targeting superparamagnetic iron oxide (SPIO) nanoparticles. Our and data demonstrate that this system can effectively inhibit both osteoclastic bone resorption and breast cancer invastion, leading to alleviated osteolysis. Therefore, the bone targeting & furin inhibition nanoparticle system is a promising therapeutic and diagnostic strategy for breast cancer bone metastasis.
乳腺癌骨转移对治疗策略构成了重大挑战。在转移环境中,破骨细胞与肿瘤细胞协同相互作用以促进癌症进展。在本研究中,由于前蛋白转化酶弗林蛋白酶在肿瘤细胞侵袭和破骨细胞功能中均发挥关键作用,因此将其作为靶点。重要的是,弗林蛋白酶抑制剂由骨靶向超顺磁性氧化铁(SPIO)纳米颗粒特异性递送。我们的[此处原文缺失部分内容]数据表明,该系统可有效抑制破骨细胞介导的骨吸收以及乳腺癌侵袭,从而减轻骨质溶解。因此,骨靶向&弗林蛋白酶抑制纳米颗粒系统是一种用于乳腺癌骨转移的有前景的治疗和诊断策略。